Your session is about to expire
← Back to Search
Non-Invasive Vagus Nerve Stimulation for PTSD
Study Summary
This trial will study if non-invasive vagus nerve stimulation can help improve symptoms of PTSD in veterans.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have experienced a traumatic event, but your symptoms do not meet the severity criteria for a diagnosis of PTSD.You have taken part in another drug study or have been given experimental drugs within the last month.I've had a head injury with unconsciousness over a minute and symptoms afterwards.I have not had major heart, artery, or neck issues, nor seizures or fainting in the past year.I do not have metal implants, severe claustrophobia, or vision problems that glasses can't fix.I have been in pain for more than 3 months or am seeing a doctor for chronic pain.I have had, or plan to have, specific therapy (CPT/PE) within a month before or during the study.I am a man aged between 21 and 65.I haven't had major surgery or uncontrolled illness in the last month.I am taking standard PTSD medications but not chronic pain or anti-inflammatory meds.
- Group 1: Transcutaneous Vagus Nerve Stimulation
- Group 2: Sham Vagus Nerve Stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment ongoing for this experiment?
"That is correct. According to clinicaltrials.gov, the trial posted on February 4th 2019 and updated in March 17th 2022 is actively recruiting patients; 88 are needed from one site."
What are the criteria for enrolling in this clinical investigation?
"This clinical test is open to 88 individuals aged 21 to 65, who have some form of inflammation. In addition, the following criteria must be met: Males between 21 and 65 years old from any background; previous deployment experience with a traumatic event plus Clinician-Administered PTSD Scale for DSM-5 (CAPS -5) symptom cluster severity criteria that score above 33 on CAPS total cut off; failure to meet CAPS - 5 symptoms clusters severity critera scoring below 20 on the CAPS total cut off; capability in adhering to study schedule and procedures along with English fluency; being able to voluntarily provide written informed consent"
To what extent has this clinical trial attracted participants?
"Affirmative. Per the details available on clinicaltrials.gov, this medical study is actively recruiting participants as of now. It was initially posted on April 2nd 2019 and has since been updated March 17th 2022. 88 prospective patients must be recruited for 1 centre to commence the trial."
Can individuals aged 85 and above participate in this research experiment?
"According to the requirements of this medical trial, patients must be between 21 and 65 years old. Separately, there are 27 trials that accept participants under 18 and 265 studies open to seniors aged over 65."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger